98%
921
2 minutes
20
Radiocontrast media is a major cause of nephrotoxic acute kidney injury(AKI). Contrast-enhanced CT(CE-CT) is commonly performed in emergency departments(ED). Predicting individualized risks of contrast-associated AKI(CA-AKI) in ED patients is challenging due to a narrow time window and rapid patient turnover. We aimed to develop machine-learning(ML) models to predict CA-AKI in ED patients. Adult ED patients who underwent CE-CT between 2016 and 2020 at an academic, tertiary, referral hospital were included. Demographic, clinical, and laboratory data were collected from electronic medical records. Five ML models based on logistic regression; random forest; extreme gradient boosting; light gradient boosting; and multilayer perceptron were developed, using 42 features. Among 22,984 ED patients who underwent CE-CT; 1,862(8.1%) developed CA-AKI. The LGB model performed the best (AUROC = 0.731). Its top 10 features, in order of importance for predicting CA-AKI, were baseline serum creatinine; systolic blood pressure; serum albumin; estimated glomerular filtration rate; blood urea nitrogen; body weight; serum uric acid; hemoglobin; triglyceride; and body temperature. Given the difficulty of predicting risk of CA-AKI in ED, this model can help clinicians with early recognition of AKI and nephroprotective point-of-care interventions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11868533 | PMC |
http://dx.doi.org/10.1038/s41598-025-86933-9 | DOI Listing |
BMC Med Inform Decis Mak
September 2025
Emergency Department, Helios Spital, Überlingen, Germany.
Background: The increasing amount of data routinely collected on ICUs poses a challenge for clinicians which is aggravated with data-heavy therapies like Continuous Kidney Replacement Therapy (CKRT). We developed the CKRT Supporting Software Prototype (CKRT-SSP), a clinical decision support system for use before, during and after CKRT. The aim of this user experience (UX) study was to prospectively evaluate CKRT-SSP in terms of usability, user experience, and workload in a simulated ICU setting.
View Article and Find Full Text PDFJ Perinatol
September 2025
University of Colorado School of Medicine, Department of Pediatrics, Aurora, CO, USA.
Objective: Determine whether acute kidney injury (AKI) is associated with subsequent late-onset infection (LOI) among extremely low gestational age newborns (ELGAN).
Study Design: Secondary analysis of participants in the Preterm Erythropoietin for Neuroprotection Trial. Infants surviving ≥7 days with sufficient serum creatinine data were included.
Ren Fail
December 2025
Department of Critical Care Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, China.
This study aimed to develop a predictive model and construct a graded nomogram to estimate the risk of severe acute kidney injury (AKI) in patients without preexisting kidney dysfunction undergoing liver transplantation (LT). Patients undergoing LT between January 2022 and June 2023 were prospectively screened. Severe AKI was defined as Kidney Disease: Improving Global Outcomes stage 3.
View Article and Find Full Text PDFJ Pediatr Urol
August 2025
Hacettepe University Medical Faculty, Department of Pediatric Surgery, Ankara, Turkey.
Background: Patients with synchronous bilateral Wilms tumor (BWT) face challenges in balancing oncological control and nephron-sparing surgery (NSS). This study aimed to identify objective criteria for NSS in BWT by applying SIOP RTSG 2016 Umbrella Study criteria, the RENAL nephrometry scoring system, three-dimensional (3D) tumor volume measurements, and residual healthy kidney volume assessment.
Methods: A retrospective analysis was conducted on 14 patients with synchronous BWT.
J Vet Med Sci
September 2025
Noto Marine Laboratory, Institute of Nature and Environmental Technology, Kanazawa University.
Local anesthetics such as lidocaine have been used in humans and other animals to perform surgical procedures, therapeutics, and experiments. Lidocaine discarded into the environment through industrial waste, human and animal excretion, and household waste has been detected in the aquatic environment. For example, lidocaine in rivers, lakes, and influent and effluent water has been detected at wastewater treatment plants (7 ng/L-2.
View Article and Find Full Text PDF